Smoking, the missing drug interaction in clinical trials: ignoring the obvious.
about
Measuring stigma in people with lung cancer: psychometric testing of the cataldo lung cancer stigma scaleHelping patients to reduce tobacco consumption in oncology: a narrative reviewSystematic Review of Tobacco Use after Lung or Head/Neck Cancer Diagnosis: Results and Recommendations for Future ResearchPatient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancerClassical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.Male tobacco smoke load and non-lung cancer mortality associations in Massachusetts.Effects of cigarette smoke on the human oral mucosal transcriptomeCYberinfrastructure for COmparative effectiveness REsearch (CYCORE): improving data from cancer clinical trialsImpact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803.Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer.Impact of smoking cessation on global gene expression in the bronchial epithelium of chronic smokers.Associations between pain and current smoking status among cancer patients.Characteristics of patients dying within 30 days of diagnosis of breast or colorectal cancer in Scotland, 2003-2007.National cancer institute conference on treating tobacco dependence at cancer centers.Cigarette smoking and outcomes after allogeneic hematopoietic stem cell transplantationPrevalence of cigarette smoking among adult cancer survivors in Korea.Smoking and cervical cancer.Tobacco use and cessation for cancer survivors: an overview for cliniciansOncology healthcare providers' implementation of the 5A's model of brief intervention for smoking cessation: patients' perceptionsDisparities between blacks and whites in tobacco and lung cancer treatment.Automated tobacco assessment and cessation support for cancer patientsTobacco Cessation May Improve Lung Cancer Patient SurvivalBioinformatics Analysis of the Effects of Tobacco Smoke on Gene ExpressionSmoking cessation counseling beliefs and behaviors of outpatient oncology providersFactors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancer.Accuracy of self-reported tobacco assessments in a head and neck cancer treatment populationTobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.How do we safely get people to stop smoking?Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis.Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical TrialsWhy do cancer patients smoke and what can providers do about it?Who tended to continue smoking after cancer diagnosis: the national health and nutrition examination survey 1999-2008.Smoking cessation interventions in cancer care: opportunities for oncology nurses and nurse scientistsPromoting a healthy lifestyle among cancer survivors.Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer.Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients.Improved survival with HPV among African Americans with oropharyngeal cancer.Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research.Second hand smoke exposure and excess heart disease and lung cancer mortality among hospital staff in Crete, Greece: a case study.
P2860
Q24635385-A219368A-2CE3-4339-82BB-5A8478EF7569Q26738416-DD802ACE-2B4A-4A7A-BD97-CB50C1EA21C9Q28085361-4F1A0327-98D0-4E67-A47B-0FAE005578E3Q28382859-8CDC6442-FF99-48EC-BBA2-819C643374FAQ30373904-4C1264CB-D0B8-4992-AA73-C8CE4BE110C8Q33386233-F5E1393A-557A-4588-8DF7-E1EC54C2C1ECQ33707973-8965442F-57B4-45A1-8E96-F7F6D1ED873AQ33880812-9402F969-D8B9-4DDA-B83E-500AB32C4A42Q33908601-BA64806A-A520-4DA0-84FB-DA2CAD3670CBQ33975327-4451B540-96B7-47F7-AD68-1DE7F5B20E3FQ34273137-BB054F87-AD30-4BFE-B835-C742B0FD8371Q34540555-E4D55657-D7DC-4254-B137-0DEF64D0F9BAQ34577587-8D96831D-826B-4036-97B2-3AA8F56460E4Q34974916-9814A42A-7B84-4581-B4E7-CC142C3ADDFFQ35043175-42934C1A-4511-4CF6-B723-F12CD2C2CB08Q35086133-CBFF8239-3209-4C01-844E-244E79C35C02Q35116969-F6822C68-FB22-41D6-A81B-A99F0E3B6533Q35226577-3084BC8E-4B5E-4154-8CAC-99FC6A1D8BA3Q35569168-FB8B181B-B759-4B67-AE9D-24754EA5120DQ35584391-EB687507-BE0B-4A78-BAF4-23BBBAB135E3Q35786702-FF256C82-CB46-4A53-A3BA-CEC737AF9005Q35828404-04750892-90FF-4490-852A-1B3F841ACBBDQ35858693-FD0B3EA5-36DB-40C9-B895-CDA351987D3BQ35863923-FD417882-B5D0-491F-A841-433C3DF934EDQ35878034-98FE0183-8417-4150-AC80-88D92C986952Q35892500-846433DD-63ED-428C-8A46-E8B2F652E92FQ35964545-156C5445-037D-4253-852F-64354988C627Q36023746-607595B7-B37B-4A45-BD7A-CBF75A1EEC0BQ36097436-B045878E-AB83-4DF3-A28F-37ED8AB005D5Q36116387-F8BC0252-49CA-4564-A9BE-BE1F5D7AADEDQ36135200-1EBCA8CD-989E-4380-8118-12A008A8B078Q36407606-252289FF-7C8C-41D6-9564-D9D33B722348Q36483966-97DE7BA8-D150-4608-A7D6-C20FB606EDA3Q36509562-7DF5F15C-F561-4414-A6FB-2FE4A0E3F055Q36657305-28146376-C0A3-41A9-898E-C123C87D633FQ36704148-045BEFBA-3718-4235-9625-DA99CA7B89DFQ36772062-80114308-7B60-4A4B-A6B6-1E9E9E20EB92Q36815283-EDB5C388-606F-4DC8-95FB-36C32543A9A3Q36883947-9B0151FA-7172-4679-831A-FAB56D856B13Q36977910-52F6A222-69B7-4739-B36B-F858C15D20AC
P2860
Smoking, the missing drug interaction in clinical trials: ignoring the obvious.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Smoking, the missing drug interaction in clinical trials: ignoring the obvious.
@ast
Smoking, the missing drug interaction in clinical trials: ignoring the obvious.
@en
type
label
Smoking, the missing drug interaction in clinical trials: ignoring the obvious.
@ast
Smoking, the missing drug interaction in clinical trials: ignoring the obvious.
@en
prefLabel
Smoking, the missing drug interaction in clinical trials: ignoring the obvious.
@ast
Smoking, the missing drug interaction in clinical trials: ignoring the obvious.
@en
P1476
Smoking, the missing drug interaction in clinical trials: ignoring the obvious.
@en
P2093
Carolyn Dresler
Linda Sarna
P304
P356
10.1158/1055-9965.EPI-05-0224
P577
2005-10-01T00:00:00Z